Literature DB >> 2909415

Kidney hemodynamics after ketone body and amino acid infusion in normal and IDDM subjects.

R Nosadini1, R Trevisan, P Fioretto, A Semplicini, B Samà, M Velussi, G L Da Campo, A Avogaro, A Vizzaccaro, V Donadon.   

Abstract

Little information is available on the hemodynamic response (renal reserve) of the diabetic kidney during an acute amino acid infusion, which has been shown to increase glomerular filtration rate (GFR) in normal humans. We recently found that the infusion of ketone bodies is able to raise GFR in both normal subjects and insulin-dependent diabetes mellitus (IDDM) patients. The aim of this study was to evaluate the renal reserve in 15 IDDM patients with a duration of diabetes of greater than 9 yr [8 with albumin excretion rate less than 15 micrograms/min (group 1) and 7 with albumin excretion rate greater than 100 micrograms/min (group 2)] and in 8 normal subjects during amino acid infusion (33 mumol.kg-1.min-1, Travasol 10% wt/vol solution containing 0.154 mM sodium chloride concentration; Travenol, Savage, MD) and during acetoacetic sodium salt (25 mumol.kg-1.min-1) infusion. Blood glucose was clamped at euglycemic levels. The infusion of sodium acetoacetate resulted in a 10- to 15-fold increase in circulating concentrations of ketone bodies, which were similar in magnitude in normal subjects and diabetic patients. The GFR peak increase above baseline after sodium acetoacetate infusion was 28% in normal subjects and 27% in group 1 and 19% in group 2 diabetic patients. The infusion of amino acid solution produced a three- to fivefold increase in plasma concentrations of amino acids in both normal subjects and diabetic patients. The GFR peak increase above baseline after amino acid infusion was significantly lower in diabetic patients (IDDM group 1: 5%, P less than .01; IDDM group 2: 6%, P less than .01) than in normal subjects (38%).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2909415     DOI: 10.2337/diab.38.1.75

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  8 in total

1.  Effect of captopril on renal functional reserve in type 1 (insulin-dependent) diabetes mellitus.

Authors:  E Jungmann; K H Usadel
Journal:  Diabetologia       Date:  1991-11       Impact factor: 10.122

2.  Effects of insulin and lipid emulsion on renal haemodynamics and renal sodium handling in IDDM patients.

Authors:  T Pelikánová; I Smrcková; J Krízová; J Stríbrná; V Lánská
Journal:  Diabetologia       Date:  1996-09       Impact factor: 10.122

Review 3.  Glomerular function reserve and sodium sensitivity.

Authors:  Genjiro Kimura
Journal:  Clin Exp Nephrol       Date:  2005-06       Impact factor: 2.801

4.  Impaired response to angiotensin II in type 1 (insulin-dependent) diabetes mellitus. Role of prostaglandins and sodium-lithium countertransport activity.

Authors:  P Fioretto; M Sambataro; M G Cipollina; E Duner; C Giorato; A Morocutti; F Mollo; G P Ben; A Carraro; D Sacerdoti
Journal:  Diabetologia       Date:  1991-08       Impact factor: 10.122

5.  Renal functional reserve in patients with Type 1 diabetes mellitus.

Authors:  Jelka Zaletel; Darko Cerne; Katarina Lenart; Sabine Zitta; Günther Jürgens; Willibald Estelberger; Andreja Kocijancic
Journal:  Wien Klin Wochenschr       Date:  2004-04-30       Impact factor: 1.704

6.  Glucose-induced changes in renal haemodynamics in proteinuric type 1 (insulin-dependent) diabetic patients: inhibition by acetylsalicilic acid infusion.

Authors:  S De Cosmo; K Earle; A Morocutti; J Walker; P Ruggenenti; G Remuzzi; G C Viberti
Journal:  Diabetologia       Date:  1993-07       Impact factor: 10.122

Review 7.  An Overview of the Cardiorenal Protective Mechanisms of SGLT2 Inhibitors.

Authors:  Teresa Salvatore; Raffaele Galiero; Alfredo Caturano; Luca Rinaldi; Anna Di Martino; Gaetana Albanese; Jessica Di Salvo; Raffaella Epifani; Raffaele Marfella; Giovanni Docimo; Miriam Lettieri; Celestino Sardu; Ferdinando Carlo Sasso
Journal:  Int J Mol Sci       Date:  2022-03-26       Impact factor: 5.923

8.  The clinical efficacy and safety of dapagliflozin in patients with diabetic nephropathy.

Authors:  Ying Huang; Wen Lu; Hongyun Lu
Journal:  Diabetol Metab Syndr       Date:  2022-03-29       Impact factor: 3.320

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.